Keigo Tsujimoto

Provides research services to pharmaceutical companies

Provides research services

Operates as a holding company with interests in pharmaceutical research and development

The company is based in Stuart. Linical Accelovance America, Inc. is a mid-sized contract research organization specializing in comprehensive drug development and clinical trial management services across all phases, from early phase studies to large-scale multinational late-phase trials. The American company provides expertise in drug development strategy, regulatory consulting, clinical trial feasibility and start-up, project management, medical affairs, pharmacovigilance, clinical monitoring, patient recruitment, biometrics, quality assurance, and medical writing. Linical focuses on therapeutic areas such as oncology, neurology and psychiatry, immunology and vaccines, endocrinology and metabolic diseases, biosimilars, rare diseases, and pediatrics. The company leverages local expertise in language, culture, patient populations, and regulatory environments to optimize trial design and ensure compliance with regulations across major markets. Linical integrates advanced technology, standardized processes, real-time project insights, and predictive analytics to deliver data efficiently. The company also supports investigator networks and offers a knowledge hub with research articles and industry resources, while investing in AI and digital tools to enhance operational efficiency and service quality. Linical Accelovance America was founded in 2004.